[go: up one dir, main page]

UA87312C2 - КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ - Google Patents

КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ

Info

Publication number
UA87312C2
UA87312C2 UAA200612949A UAA200612949A UA87312C2 UA 87312 C2 UA87312 C2 UA 87312C2 UA A200612949 A UAA200612949 A UA A200612949A UA A200612949 A UAA200612949 A UA A200612949A UA 87312 C2 UA87312 C2 UA 87312C2
Authority
UA
Ukraine
Prior art keywords
aerosol inhalation
agonists
composition
xtake
rand
Prior art date
Application number
UAA200612949A
Other languages
English (en)
Ukrainian (uk)
Inventor
Майкл Эйвен
Original Assignee
Бьёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA87312(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бьёрингер Ингельхайм Интернациональ Гмбх filed Critical Бьёрингер Ингельхайм Интернациональ Гмбх
Publication of UA87312C2 publication Critical patent/UA87312C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

В заявке описана лекарственная композиция для аэрозольной ингаляции без пропеллента, которая содержит одно или несколько соединений общей формулы (1)(1),где остатки R, R, Rи Xпринимают значения, указанные в формуле изобретения и описании.
UAA200612949A 2004-05-14 2005-05-10 КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ UA87312C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten

Publications (1)

Publication Number Publication Date
UA87312C2 true UA87312C2 (ru) 2009-07-10

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612949A UA87312C2 (ru) 2004-05-14 2005-05-10 КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ

Country Status (26)

Country Link
EP (1) EP1809293B1 (ru)
JP (1) JP4620730B2 (ru)
KR (1) KR101288791B1 (ru)
CN (1) CN101056640A (ru)
AR (1) AR049096A1 (ru)
AU (1) AU2005244414B2 (ru)
BR (1) BRPI0511135B8 (ru)
CA (1) CA2564379C (ru)
DE (1) DE102004024452A1 (ru)
DK (1) DK1809293T3 (ru)
EA (1) EA012583B1 (ru)
EC (1) ECSP067004A (ru)
ES (1) ES2575925T3 (ru)
HU (1) HUE027780T2 (ru)
IL (1) IL179218A (ru)
MX (1) MXPA06013216A (ru)
MY (1) MY148403A (ru)
NO (1) NO20065030L (ru)
PE (1) PE20060311A1 (ru)
PL (1) PL1809293T3 (ru)
SG (1) SG152265A1 (ru)
TW (1) TWI356703B (ru)
UA (1) UA87312C2 (ru)
UY (1) UY28891A1 (ru)
WO (1) WO2005110421A2 (ru)
ZA (1) ZA200607462B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
KR101360803B1 (ko) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
CA2738617A1 (en) * 2008-11-21 2011-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
JP2012509298A (ja) * 2008-11-21 2012-04-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング β作用薬吸入用のエアロゾル製剤
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
SI2422786T1 (sl) * 2004-04-22 2014-12-31 Boehringer Ingelheim International Gmbh Nove farmacevtske kombinacije za zdravljenje respiratornih obolenj
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten

Also Published As

Publication number Publication date
AU2005244414A1 (en) 2005-11-24
BRPI0511135B8 (pt) 2021-05-25
KR101288791B1 (ko) 2013-07-29
PE20060311A1 (es) 2006-05-08
DK1809293T3 (en) 2016-06-20
ECSP067004A (es) 2007-02-28
BRPI0511135B1 (pt) 2019-11-12
ES2575925T3 (es) 2016-07-04
IL179218A (en) 2012-10-31
WO2005110421A2 (de) 2005-11-24
BRPI0511135A (pt) 2007-11-27
MY148403A (en) 2013-04-30
UY28891A1 (es) 2005-12-30
TWI356703B (en) 2012-01-21
PL1809293T3 (pl) 2016-09-30
SG152265A1 (en) 2009-05-29
KR20070022084A (ko) 2007-02-23
JP2007537188A (ja) 2007-12-20
CN101056640A (zh) 2007-10-17
EP1809293A2 (de) 2007-07-25
NO20065030L (no) 2006-11-30
MXPA06013216A (es) 2007-02-08
AU2005244414B2 (en) 2010-12-09
ZA200607462B (en) 2008-06-25
CA2564379C (en) 2013-07-30
HUE027780T2 (en) 2016-11-28
TW200608981A (en) 2006-03-16
IL179218A0 (en) 2007-03-08
JP4620730B2 (ja) 2011-01-26
WO2005110421A3 (de) 2006-03-16
EA200602017A1 (ru) 2007-06-29
AR049096A1 (es) 2006-06-28
EA012583B1 (ru) 2009-10-30
EP1809293B1 (de) 2016-03-16
CA2564379A1 (en) 2005-11-24
DE102004024452A1 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
DE602004021472D1 (en) Pyrimiidinverbindungen
WO2006073457A8 (en) Bioactive compounds and methods of uses thereof
TW200800999A (en) Novel compounds
WO2007106192A3 (en) Inhibitors of iap
WO2003095455A3 (en) Substituted pyrazolopyrimidines
TW200508214A (en) Novel compounds
TW200801003A (en) Novel compounds
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
TW200738659A (en) Novel compounds
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
TW200716529A (en) New compounds II
TW200736227A (en) New compounds III
TW200639156A (en) New compounds
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
WO2007120333A3 (en) Tetracyclic kinase inhibitors
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200744612A (en) New combination
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ